.png){kind=icon}
皮肤病药物开发
With deep scientific acumen and rich medical expertise, Covance, a global CRO, provides patient-centric solutions, cutting edge counsel and Enterprise-wide Centers of Excellence that yield true value in the form of transformative insights and applied market impact.
Advance your dermatology program by partnering with Covance. Together, we complement your scientific expertise and help inspire patient-centric solutions across many dermatological indications and study phases.
增加皮肤病学患者的生活质量
Add value to your dermatology program with the experience of our medical and clinical research professionals who specialize in the full spectrum of pharmaceutical and cosmetic development
伙伴with Covance professionals with expertise in dermatology endpoint assessments, including investigator scales, patient-reported outcomes and photographic imaging around the globe
在竞争激烈的环境中找到合适的患者和地点 - 唯一只有来自大多数全球临床试验的调查员数据将世界上最大的去鉴定患者诊断和情报数据中的最大来源之一
治疗经验
您需要一个可以预测与您的学习相关的潜在挑战的合作伙伴。Covance在皮肤科中具有广泛的全球治疗和操作经验。全球经验包括163研究involving28092名患者从2,831 sites穿过53 countries在过去的五年中。
通过专业从事全谱的药物和美容发展，为您的项目添加价值，以专业知识，经验和领导。作为跨职能团体工作，该团队与您合作，提供医疗，运作，监管和成本效率的观点的皮肤病。您可以利用我们促进的行业领导者，包括摄影和皮肤病病核心实验室的关系，以提供洞察力和战略指导，这导致更好的患者体验，改善临床结果和加快监管批准。
Dermatology assessment scales & photography
为了成功进行临床试验，您需要使用调查员秤，患者报告的结果和摄影成像进行皮肤科终点评估。依靠我们的专业知识为您的审判选择适当的疾病特定评估，因为我们专注于确保数据质量和集成到电子数据捕获（EDC）系统。
了解患者
皮肤病学患者的疾病负担包括生理和心理社会尺寸，对生活质量（QOL）产生重大影响。景气了解这种复杂的互动，并通过临床发展致力于皮肤病学的进步。因此，我们与皮肤病学审判中经历的皮肤科医生合作，他们深入了解患者的疾病负担。
As with any trial, it is important to take into account the patient perspective in patient enrollment, and understand that dermatology trials require extra attention. Dermatological conditions are multi-faceted as they not only impact QoL, but also span across all age groups, which demand varying sensitivities. For example, requirements for recruitment and retention of an adult patient would predictably differ from enrolling pediatric and adolescent patients, thus requiring specialized care and sensitivity to the patient and family. With the help of our dedicated罕见的疾病和儿科团队我们完全对齐，以帮助您进行临床发展战略。
除了稀有疾病和儿科团队外，Covance还具有直接患者的反馈，并在各种条件下进行了患者外展的专有声音，包括皮肤科。这些见解可以进一步用于开发患者友好的协议，并更好地了解包含和排除标准对患者招募和保留的影响。
Access to Experienced Sites and Patients
获得经验丰富的网站和患者是成功试验的关键，在竞争环境中尤其如此。我们的Xcellerate®预测和网站选择tool is one of the largest in the pharmaceutical industry – and provides Covance with unique capabilities to optimize site selection based on industry-wide metrics. This information ensures that low performing sites are eliminated from the outset and resources are re-focused for optimal efficiency.
在美国，通过我们的母公司Labcorp，Covance还可以访问庞大的患者和临床医生实验室测试价值数据库。This database covers over 500,000 samples processed daily, with a total of over 16 billion test results overall from over 790,000 unique clinicians in the U.S. Through these data, Covance has unique solutions available to understand the impact of a study’s inclusion/exclusion criteria and identify clusters of patients to optimally locate potential investigators.
我们的Xcellerate®数据和Labcorp数据的组合在找到右位招聘患者的权力方面表现出电源。在先前的皮肤病学研究（可通过指示搜索）的高性能网站可以通过显示患者的Labcorp数据集进行交叉引用，显示ICD诊断令人兴趣守则的位置。以这种方式，可以识别高表现位点并交叉参考高患者密度的区域。这两个专有的数据来源和工具是Covance独有的，并为您的学习找到合适的网站提供有价值的洞察力。